Pharma and BioTech Daily
Pharma and BioTech News
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech.Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences.Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
Notable Guests
Episodes (318)
FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily
Pharma and BioTech Daily
Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily
Pharma and BioTech Daily
AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily
Pharma and BioTech Daily
FDA Approves Alzheimer's Drug: Major $ Breakthrough | Pharma and Biotech Daily
Pharma and BioTech Daily
Ionis' Zanvastro FDA Approved: $771M Partnership Impact | Pharma and Biotech Dai...
Pharma and BioTech Daily
Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotec...
Pharma and BioTech Daily
AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily
Pharma and BioTech Daily
Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily
Pharma and BioTech Daily
Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily
Pharma and BioTech Daily
Eli Lilly's $173M FDA Win: Mounjaro Approved! | Pharma and Biotech Daily
Pharma and BioTech Daily
Revolution Medicines' $2.25B FDA Approval Milestone | Pharma and Biotech Daily
Pharma and BioTech Daily
Revolution Medicines FDA Win: RAS Inhibitor Approved | Pharma and Biotech Daily
Pharma and BioTech Daily
FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily
Pharma and BioTech Daily
Roche & Hanmi's $2.5B Obesity Drug Deal | Pharma and Biotech Daily
Pharma and BioTech Daily
Roche's $750M Genentech Expansion Boosts Biologics | Pharma and Biotech Daily
Pharma and BioTech Daily
Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily
Pharma and BioTech Daily
Merck's $1B Melanoma Vaccine Breakthrough | Pharma and Biotech Daily
Pharma and BioTech Daily
Biokin's $275M ADC Success in Phase 3 Trial | Pharma and Biotech Daily
Pharma and BioTech Daily
AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC | Pharma and Biotech...
Pharma and BioTech Daily
FDA Fast-Tracks NASH Drug | Pharma and Biotech Daily
Pharma and BioTech Daily
AstraZeneca's Baxfendy Setback: Pricing Woes | Pharma and Biotech Daily
Pharma and BioTech Daily
Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily
Pharma and BioTech Daily
Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs | Pharma and Biotech D...
Pharma and BioTech Daily
Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough | Pharma and Biote...
Pharma and BioTech Daily
Replimune's FDA Win: Tudriqev Approved After 2 Rejections | Pharma and Biotech D...
Pharma and BioTech Daily
Moderna mRNA Flu Vaccine Approved by FDA | Pharma and Biotech Daily
Pharma and BioTech Daily
Eli Lilly's $23B Q2 Revenue Breaks Records | Pharma and Biotech Daily
Pharma and BioTech Daily
Otsuka's Voyxact Shines in Phase 3 Trial | Pharma and Biotech Daily
Pharma and BioTech Daily
Supernus & Indivior $2.2B Merger Creates CNS Giant | Pharma and Biotech Daily
Pharma and BioTech Daily
Replimune's Breakthrough in Cancer Therapy | Pharma and Biotech Daily
Pharma and BioTech Daily
Johnson & Johnson's $785M CAR-T Deal & More | Pharma and Biotech Daily
Pharma and BioTech Daily
Biogen Acquires Apellis for Growth | Pharma and Biotech Daily
Pharma and BioTech Daily
GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Dail...
Pharma and BioTech Daily
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
Pharma and BioTech Daily
Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily
Pharma and BioTech Daily
Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Dail...
Pharma and BioTech Daily
Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily
Pharma and BioTech Daily
Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily
Pharma and BioTech Daily
Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily
Pharma and BioTech Daily
Jasper Merges with Kira for $292M | Pharma and Biotech Daily
Pharma and BioTech Daily
Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol | Pharma and Biote...
Pharma and BioTech Daily
Veradermics' $2B Hair Loss Market Move with Oral Minoxidil | Pharma and Biotech...
Pharma and BioTech Daily
Biogen's $1.5B Deal & FDA Approval for Alzheimer's Drug | Pharma and Biotech Dai...
Pharma and BioTech Daily
Pfizer & Merck's $3B Bladder Cancer Breakthrough | Pharma and Biotech Daily
Pharma and BioTech Daily
Sanofi's FDA Approval: $160M Boost for Sarclisa in Cancer Care | Pharma and Biot...
Pharma and BioTech Daily
Ipsen's Dysport Hits Phase 3 Milestone vs. Botox | Pharma and Biotech Daily
Pharma and BioTech Daily
Vera Therapeutics' Trutakna Gets FDA Nod for IgA Nephropathy | Pharma and Biotec...
Pharma and BioTech Daily
Vertex Acquires Crinetics for $10B | Pharma and Biotech Daily
Pharma and BioTech Daily
Novartis' $1.1B Myricx Acquisition Boosts ADC Pipeline | Pharma and Biotech Dail...
Pharma and BioTech Daily
FDA Accelerated Approval: New Drug for Breast Cancer | Pharma and Biotech Daily
Pharma and BioTech Daily